XORTX Therapeutics Inc (XRTX)

NASDAQ: XRTX · IEX Real-Time Price · USD
1.71
-0.09 (-5.00%)
At close: Jan 21, 2022 4:00 PM
1.67
-0.04 (-2.34%)
After-hours:Jan 21, 2022 5:31 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019
Selling, General & Admin
0.530.29
Research & Development
0.280.04
Other Operating Expenses
0.560.24
Operating Expenses
1.370.57
Operating Income
-1.37-0.57
Interest Expense / Income
0.010.04
Other Expense / Income
-0.090.03
Pretax Income
-1.28-0.63
Net Income
-1.28-0.63
Net Income Common
-1.28-0.63
Shares Outstanding (Basic)
75
Shares Outstanding (Diluted)
75
Shares Change
24.34%-
EPS (Basic)
-0.19-0.12
EPS (Diluted)
-0.19-0.12
Free Cash Flow Per Share
-0.19-0.12
EBITDA
-1.25-0.57
EBIT
-1.27-0.59
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).